Related Experiment Videos

TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges

Anita C Bellail1, Ling Qi, Patrick Mulligan

  • 1Department of Pathology & Laboratory Medicine, 1365-C Clifton Road, Atlanta, GA, USA.

Reviews on Recent Clinical Trials
|January 20, 2009
PubMed

Insights

Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) shows promise in cancer therapy by activating apoptosis in cancer cells. TRAIL agonists are advancing through clinical trials, offering new hope for effective cancer treatments.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) is a key immune system protein involved in antitumor responses.
  • TRAIL initiates programmed cell death (apoptosis) in cancer cells by binding to death receptors DR4 and DR5.

Purpose of the Study:

  • To review the development of TRAIL-based cancer therapeutics.
  • To discuss the advances and challenges in using TRAIL agonists in clinical settings.

Main Methods:

  • Development of recombinant human TRAIL (rhTRAIL) and agonistic monoclonal antibodies (MAbs) targeting DR4/DR5.
  • Evaluation of safety and tolerability in Phase I clinical trials.
  • Assessment of therapeutic efficacy in Phase II clinical trials, both as monotherapy and in combination treatments.

Main Results:

  • Phase I trials confirmed the safety and tolerability of TRAIL agonists.
  • Phase II trials are ongoing to determine the efficacy of these agents in cancer patients.

Conclusions:

  • TRAIL agonists represent a promising class of cancer therapeutics.
  • Further research and clinical evaluation are necessary to overcome challenges and establish TRAIL agonists as effective treatments.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...